ALTSTATION.IO

DuPont de Nemours, Inc. (DD) Stock Analysis

By Nova Skye | AltStation.io | Updated November 01, 2026

Price

$140.05

Change

-0.38%

Market Cap

$18.91B

Avg Volume

1.1M

Company Overview

DuPont de Nemours, Inc. is a Wilmington, Delaware-based specialty chemicals company operating within the Basic Materials sector. The business sells high-performance engineered materials, protective barriers, and water purification technologies to industrial buyers across seven geographic regions. Their core catalog relies on established, premium brands like TYVEK for protective garments and medical packaging, FILMTEC and AMBERLITE for municipal water desalination and wastewater treatment, and STYROFOAM and CORIAN for building construction. They also supply specialized industrial components, including Vespel parts, BETAFORCE adhesives, and MOLYKOTE lubricants to automotive, aerospace, and commercial printing manufacturers.

DuPont functions as an established leader in high-spec specialty niches rather than a generic commodity chemical producer. Their real moat comes from heavily specified, proprietary brands like TYVEK, FILMTEC, and Vespel, which carry substantial switching costs in regulated medical, aerospace, and municipal water filtration operations. The vulnerability is cyclicality: their Diversified Industrials arm remains directly exposed to macro slowdowns in automotive build rates, commercial printing demand, and residential housing construction. Maintaining pricing power across these diverse end markets requires strict cost management against competing chemical formulators.

The company is operating as a significantly streamlined specialty business following its corporate split from DowDuPont and official rebranding in June 2019. DuPont has consolidated its global operations into two distinct reporting units: Healthcare & Water Technologies and Diversified Industrials. This two-segment structure strategically pivots capital toward secular drivers like global water desalination, industrial wastewater filtration, and sterile medical packaging. Compared to the massive conglomerate originally incorporated in 2015, today’s DuPont is a more disciplined operator targeting essential engineering and separation technologies.

Key Financials

Market Cap

$18.91B

Revenue

$6.99B

EBITDA

$1.58B

Gross Margin

35.1%

Profit Margin

0.8%

Revenue Growth

4.0%

Total Cash

$1.74B

Total Debt

$3.18B

Free Cash Flow

$1.84B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

37.65

Forward P/E

17.55

Beta

1.08

52-Week High

$157.98

52-Week Low

$100.02

EPS

$3.72

50-Day Avg

$132.22

200-Day Avg

$138.44

Price/Book

1.37

Technical Analysis

DD trades at $140.05, 72% of the way from its 52-week low of $98.29 to its 52-week high of $156.04. The stock is 10.25% below that high and 42.49% above the low. Momentum is positive, with gains of 2.56% over five trading days and 7.75% over 20 trading days. The price is 4.97% above its 20-day moving average of $133.42. Near-term support is $128.48, while resistance sits just above the current price at $140.58.

Recent News and Developments

DuPont climate targets win SBTi validation

DuPont said on October 29 that SBTi validated its target of reaching net-zero greenhouse gas emissions across its value chain by 2050. The company committed to cutting Scope 1 and 2 emissions 83% by 2035 from 2019 levels and Scope 3 emissions 63% from a 2020 baseline. Source: DuPont

DuPont heads into third-quarter earnings

DuPont is scheduled to report before the market opens on November 3. The published Wall Street estimate is adjusted earnings of $1.87 per share. Source: Kiplinger

DD shares gain 2.56% for the week

DuPont closed at $140.05 on October 30, up 2.56% from its October 23 close of $136.55. Shares gained for three consecutive sessions from October 27 through October 29 before slipping 0.38% on Friday. Source: Stock Analysis

Market Sentiment and Analyst Recommendations

Bull Case

Revenue is growing 4.0%, giving DuPont a positive operating backdrop rather than a shrinking top line. The stock also has strong momentum, rising 7.75% over the last 20 trading days and trading 4.97% above its 20-day moving average. Wall Street’s average target of $165.29 implies meaningful upside from the current $140.05 price. The highest analyst target reaches $186.00, while even the low target of $145.00 remains above the current price. All 17 analysts behind the reported consensus combine for a buy recommendation. Investors would buy here for positive revenue growth, strong recent momentum, and analyst targets that still sit above the market price.

Bear Case

The P/E ratio of 37.65 is demanding for a company growing revenue by 4.0%. That valuation leaves little room for weak results or slower growth. DuPont also carries $3.18 billion in total debt against $1.74 billion in total cash, a gap of $1.44 billion. At $140.05, the stock is only $0.53 below near-term resistance at $140.58. It has already climbed 42.49% from its 52-week low, so buyers are no longer entering near the bottom of the range. The core risk is straightforward: investors are paying a high earnings multiple for modest revenue growth and a balance sheet with more debt than cash.

What to Watch

DuPont is scheduled to report third-quarter earnings before the market opens on November 3. The published Wall Street estimate is adjusted earnings of $1.87 per share, making that the immediate benchmark. Investors should also watch whether revenue growth holds at 4.0% or changes after the report. A move above $140.58 would clear the current 30-day high, while a decline below the $133.42 moving average would weaken the recent momentum signal. The more important downside level is $128.48, the 30-day low and stated near-term support. DuPont’s validated climate plan also creates long-term execution markers: an 83% reduction in Scope 1 and 2 emissions by 2035, a 63% reduction in Scope 3 emissions, and net-zero value-chain emissions by 2050.

Analyst Consensus

BUY

Based on 17 analyst opinions

Low Target

$145.00

Mean Target

$165.29

High Target

$186.00

Earnings and Financial Data

Sector

Basic Materials

Industry

Specialty Chemicals

Employees

15,000

Earnings & Dividends

Next Earnings

Nov 03, 2026

EPS (Trailing)

$3.72

Dividend Yield

171.0%

Payout Ratio

81.5%

Frequently Asked Questions

Is DD a good stock to buy?

DD has a buy recommendation from 17 analysts, 4.0% revenue growth, and positive five-day and 20-day momentum. The takeaway is that the data supports a bullish view, but the 37.65 P/E makes valuation the main concern.

What is DD’s price target?

The average analyst target is $165.29, with estimates ranging from $145.00 to $186.00. The takeaway is that every listed target is above the current $140.05 price.

What is DD’s 52-week range?

The key data lists a 52-week range of $100.02 to $157.98, while the computed price series shows a low of $98.29 and a high of $156.04. The takeaway is that the technical series places DD 72% of the way from its low to its high.

Is DD overvalued?

DD trades at a P/E ratio of 37.65 while revenue is growing 4.0%. The takeaway is that investors are paying a high earnings multiple relative to the reported growth rate.

Does DD pay a dividend?

The provided data does not include dividend information. The takeaway is that investors should verify DD’s current dividend details separately before making an income-based decision.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated November 01, 2026.